Baker Tilly Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$730K Buy
1,456
+440
+43% +$211K 0.16% 128
2026
Q1
$499K Sell
1,016
-351
-26% -$190K 0.12% 157
2025
Q4
$792K Buy
1,367
+105
+8% +$59.4K 0.2% 110
2025
Q3
$612K Sell
1,262
-349
-22% -$162K 0.14% 133
2025
Q2
$653K Sell
1,611
-12
-0.7% -$5.02K 0.23% 103
2025
Q1
$808K Buy
1,623
+69
+4% +$37.4K 0.32% 78
2024
Q4
$808K Sell
1,554
-46
-3% -$25.3K 0.32% 74
2024
Q3
$990K Sell
1,600
-105
-6% -$62.2K 0.44% 55
2024
Q2
$943K Sell
1,705
-3,768
-69% -$2.16M 0.39% 57
2024
Q1
$3.18M Buy
5,473
+1,862
+52% +$1.04M 0.58% 33
2023
Q4
$1.92M Sell
3,611
-291
-7% -$141K 0.31% 71
2023
Q3
$1.98M Sell
3,902
-379
-9% -$202K 0.33% 68
2023
Q2
$2.23M Sell
4,281
-605
-12% -$326K 0.23% 92
2023
Q1
$2.82M Sell
4,886
-926
-16% -$522K 0.32% 69
2022
Q4
$3.2M Buy
5,812
+4,761
+453% +$2.52M 0.39% 66
2022
Q3
$533K Sell
1,051
-42
-4% -$23.5K 0.07% 279
2022
Q2
$594K Buy
1,093
+67
+7% +$36.9K 0.08% 260
2022
Q1
$606K Buy
1,026
+199
+24% +$114K 0.07% 294
2021
Q4
$552K Buy
827
+162
+24% +$101K 0.06% 332
2021
Q3
$380K Buy
665
+78
+13% +$42.8K 0.05% 375
2021
Q2
$296K Sell
587
-211
-26% -$99.6K 0.05% 400
2021
Q1
$364K Buy
+798
New +$381K 0.07% 311

Other funds holding TMO

Baker Tilly Wealth Management's TMO Position: Q2 2026 in Review

Baker Tilly Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 43% in Q2 2026, buying an estimated $211K and bringing the position to 1,456 shares worth $730K. The position accounts for 0.16% of the portfolio, ranked #128.

Baker Tilly Wealth Management first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.2M in Q4 2022. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Baker Tilly Wealth Management held 1,456 shares of Thermo Fisher Scientific worth $730K as of Q2 2026.
  • Baker Tilly Wealth Management bought 440 Thermo Fisher Scientific shares in Q2 2026, an estimated $211K.
  • Thermo Fisher Scientific made up 0.16% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #128 holding.
  • Baker Tilly Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • Baker Tilly Wealth Management's Thermo Fisher Scientific position peaked at $3.2M in Q4 2022.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.